PDCD1 and systemic lupus erythematosus: Thus, in future studies, larger sample sizes of SLE patients with NPLE are required to explore the correlation between the MFI of TIM-3 on TIM-3+PD-1+ NK cells and anti-RIB-P positivity in SLE patients with NPLE.